Track Exor N.V.'s EBIT ($15B) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Dec 31, 2025
Trailing 12 months ending Dec 31, 2025
The latest EBIT for EXO.AS is $15B as of December 2025. That compares with $7.3B in the prior-year period — up 108.8% year over year. That is below the sector sector average of $2.6T. Investors often review this figure alongside Exor N.V.'s historical trend and sector peers before judging valuation or financial health.
Over the past year, EXO.AS's EBIT moved from $7.3B to $15B — a 108.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Exor N.V.'s operating scale or balance-sheet position.
Against its sector companies, EXO.AS currently prints $15B for EBIT, while the sector average sits near $2.6T. That is roughly 99.4% below the sector mean. Large gaps often invite a closer look at Exor N.V.'s growth, margins, and balance sheet.
A EBIT figure of $15B for EXO.AS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.6T. Explore the charts below for those layers of context.
After noting EXO.AS's EBIT ($15B), review year-over-year change from $7.3B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.